Targeted growth factor delivery using natural polysaccharide materials for bone regeneration

使用天然多糖材料靶向输送生长因子以促进骨再生

• 批准号: LP100100504
• 负责人: Em/Prof John Whitelock
• 金额: $ 16.76万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-12-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP100100504
• 关键词: Targeted; growth; factor; delivery; using

This proposal addresses the core issue of nano-biomaterials capable of encouraging bone growth and providing better and more complete healing of bone fractures. Australia will benefit firstly through improved health outcomes by providing material-based solutions to address slow or non-healing fractures, which are increasingly prevalent in the aging population in Australia. This will have a further benefit to the Australian economy improving the quality of life enabling people to work longer and reducing the need for further surgical intervention. This proposal will also have benefits to Australia through training future researchers in this field which will in turn provide economic growth through the development of Australian industries.

这项建议解决了纳米生物材料的核心问题，该材料能够促进骨骼生长，并提供更好和更完整的骨折愈合。澳大利亚将首先受益于改善健康状况，提供基于材料的解决方案来解决缓慢或不可愈合的骨折，这些骨折在澳大利亚老龄化人口中日益普遍。这将对澳大利亚经济有进一步的好处，改善生活质量，使人们能够更长时间地工作，并减少进一步手术干预的需要。这项提议还将通过培训这一领域的未来研究人员而使澳大利亚受益，这反过来又将通过发展澳大利亚的工业来促进经济增长。